| ADHD (Attention Deficit Hyperactivity Disorder) |
| Metastatic, prior therapy |
| Other (Digestive System Cancer) |
| Prostate, d2 hormone sensitive |
| Renal, metastatic, 3rd line |
| Other (Genito-Urinary Cancer) |
| Endometrial Cancer, Stage III Or IV, Recurrent |
| Endometrial Cancer, Advanced |
| Endometrial Cancer, Recurrent/Persistent |
| Ovary, Peritoneal, Recurrent/Persistent |
| Ovary, Peritoneal, Recurrent/Persistent, Platinum Sensitive |
| Ovary, Peritoneal, Tubal-Untreated, All Stages |
Ovary, Peritoneal w/Complete Response
to Platinum/Taxane Chemotherapy |
| Cervix, Advanced, Invasive, No Prior Therapy |
| Gestational Trophoblastic Neoplasia |
| Other (Gynecological Cancer) |
| Leukemia/Hematologic Malignancies |
| MDS/Myeloproliferative Disorder |
| Low Tumor Burden, Indolent |
| Relapsed Or Progressing After Transplant |
| Newly Diagnosed Glioblastoma Multiforme |
| Other (Pediatric Oncology) |
| Non Small Cell, Panacoast Tumors |
| Non Small Cell Advanced, Prior Therapy |
| Small Cell, Extensive Recurrent |
| Leukemia/Hematologic Malignancies |
| Esophageal Cancer and Barrett's Esophagus |
| Post Traumatic Stress Disorder |
| Amyotrophic Lateral Sclerosis |
|
Trial
Name
A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I or II Breast Cancer
...
more
A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers
...
more
This research study is designed to learn whether different anti-HIV medication ("HAART") combinations work equally well in participants who have never taken anti-HIV medications before.
...
more
NSABP B-37: A Randomized Clinical Trial of Adjuvant Chemotherapy for Radically Resected Loco-Regional Relapse of Breast Cancer.
...
more
IBCSG 24-02: A Phase III Trial Evaluating the Role of Ovarian Function Suppression and the Role of Exemestane as Adjuvant Therapies for Premenopausal Women with Endocrine Responsive Breast Cancer
...
more
S 0230: Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Standard Adjuvant Chemotherapy in Early Stage, Hormone Receptor Negative Breast Cancer
...
more
CALGB 40101: Cyclophosphamide and Doxorubicin (CA) versus Paclitaxel as Adjuvant Therapy for Women with Node-Negative Breast Cancer: A 2x2 Factorial Phase III Randomized Study
...
more
A Randomized Trial Comparing the Safety and Efficacy of Adriamyci |